Cargando…
One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms
After COVID-19, some patients develop long-term symptoms. Whether such symptoms correlate with immune responses, and how long immunity persists, is not yet clear. This study focused on mild COVID-19 and investigated correlations of immunity with persistent symptoms and immune longevity. Persistent c...
Autores principales: | Rank, Andreas, Tzortzini, Athanasia, Kling, Elisabeth, Schmid, Christoph, Claus, Rainer, Löll, Eva, Burger, Roswitha, Römmele, Christoph, Dhillon, Christine, Müller, Katharina, Girl, Philipp, Hoffmann, Reinhard, Grützner, Stefanie, Dennehy, Kevin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347559/ https://www.ncbi.nlm.nih.gov/pubmed/34362088 http://dx.doi.org/10.3390/jcm10153305 |
Ejemplares similares
-
Impact of age and gender on lymphocyte subset counts in patients with COVID‐19
por: Löhr, Phillip, et al.
Publicado: (2021) -
Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination
por: Dennehy, Kevin M., et al.
Publicado: (2021) -
Sustained cellular immunity in adults recovered from mild COVID‐19
por: Rank, Andreas, et al.
Publicado: (2021) -
Performance of the VitaPCR rapid molecular test for SARS-CoV-2 screening at hospital admission
por: Schuierer, Lukas, et al.
Publicado: (2023) -
Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests
por: Kahn, Maria, et al.
Publicado: (2021)